Viewing Study NCT05981157


Ignite Creation Date: 2025-12-24 @ 6:54 PM
Ignite Modification Date: 2025-12-25 @ 4:27 PM
Study NCT ID: NCT05981157
Status: RECRUITING
Last Update Posted: 2023-08-08
First Post: 2023-05-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Anrotinib and Tirelizumab in First-line Treatment of RM-NPC
Sponsor: Zhongshan People's Hospital, Guangdong, China
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module